About Us: Investment Strategy
MPM invests in biotechnology, specialty pharma, medical technology, and related companies that provide innovative medical products and requisite services to the healthcare industry, irrespective of geography, stage of development and therapeutic area. We seek to maximize value creation by focusing on inflection points in the development of companies, such as the achievement of clinical proof-of-concept data, the achievement of early commercial success, and by reinvigorating commercial platforms with potentially high growth assets. We believe that by investing at or near a company's value inflection points, and by lending our internal expertise to management teams, we can often significantly accelerate the development of a company, and in the process, accelerate returns. Also with our commitment to build companies, we can help focus a company's investments on the projects and opportunities with the highest reward/risk ratio.